{"id":"W2120629149","doi":"10.3109/10428194.2012.737917","title":"A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186","year":2012,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network; McGill University; Jewish General Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Sorafenib; Myeloid leukemia; Myelodysplastic syndromes; Oncology; Rash; Cancer; Leukemia; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004461394,0.001018644,0.003218067,0.0007349337,0.0003733609,0.0000655,0.0007645455,0.0006498198,0.00008832252],"category_scores_gemma":[0.002162233,0.000639996,0.0002118794,0.002170067,0.0008111128,0.0009244379,0.0003553948,0.0008247761,0.000003502907],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01914441,"about_ca_system_score_gemma":0.03366124,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4478241,"about_ca_topic_score_gemma":0.2799508,"domain_scores_codex":[0.9892795,0.001769178,0.003387392,0.001275042,0.002927293,0.00136161],"domain_scores_gemma":[0.9920039,0.003532439,0.002082812,0.0009160293,0.0007507444,0.0007140394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5228918,0.01920349,0.3511044,0.000411487,0.004264914,0.00118674,0.004812072,0.000845796,0.000607884,0.0001954269,0.002011264,0.09246473],"study_design_scores_gemma":[0.4336704,0.01689427,0.5442885,0.0007774996,0.0008461378,0.0001119721,0.0006382918,0.001646998,0.0002027155,0.00004011871,0.0003148206,0.0005682796],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992062,0.0002328288,0.00004158457,0.0001730749,0.0007097117,0.00591084,0.0007624649,0.00005072095,0.000056714],"genre_scores_gemma":[0.9967535,0.0003146539,0.000367627,0.0003210198,0.0004594463,0.0008724123,0.0005864974,0.0001380412,0.000186827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1931841,"threshold_uncertainty_score":0.9996051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03020316122113193,"score_gpt":0.3264832382603513,"score_spread":0.2962800770392194,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}